Simvastatin inhibits malignant transformation following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts.

Johannes Fürst; Thomas Haller; Sabine Chwatal; Ewald Wöll; Peter C Dartsch; Martin Gschwentner; Anton Dienstl; Heinz Zwierzina; Florian Lang; Markus Paulmichl

doi:10.1159/000047823

Simvastatin inhibits malignant transformation following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts.

Identifier:nobleid.org/w1/20260515/A2C342DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A2C342DF.svg?ark=w1%2F20260515%2FA2C342DF)](https://nobleid.org/work/w1/20260515/A2C342DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Simvastatin inhibits malignant transformation following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts.

Identifier:nobleid.org/w1/20260515/A2C342DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A2C342DF.svg?ark=w1%2F20260515%2FA2C342DF)](https://nobleid.org/work/w1/20260515/A2C342DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work